PUBLICATION REGISTRY

Go to research.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för lumiracoxib. Visa hela publikationsregistret

A publication hit is not a conclusion. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publications in the selection

10 hits

Bibliografisk träff 2012-06-26

Cardiovascular safety of lumiracoxib: a meta-analysis of randomised controlled trials in patients with osteoarthritis.

Mackenzie IS, Wei L, Macdonald TM.

Eur J Clin Pharmacol · meta-analysis; research support, non-u.s. gov't; review-article; randomized controlled trial; journal article · DOI 10.1007/s00228-012-1335-1

Bibliografisk träff 2012-06-01

Severe acute liver injury associated with lumiracoxib.

Pillans PI, Ghiculescu RA, Lampe G, Wilson R, Wong R, Macdonald GA.

J Gastroenterol Hepatol · journal article; case reports · DOI 10.1111/j.1440-1746.2011.07036.x

Bibliografisk träff 2012-06-01

Lessons from Lumiracoxib: are cyclooxygenase-2 inhibitors less hepatotoxic than non-selective non-steroidal anti-inflammatory drugs?

Chitturi S, Farrell GC.

J Gastroenterol Hepatol · comment; editorial · DOI 10.1111/j.1440-1746.2012.07142.x

Bibliografisk träff 2011-06-20

Determination of lumiracoxib by a validated stability-indicating MEKC method and identification of its degradation products by LC-ESI-MS studies.

Sangoi MS, Wrasse-Sangoi M, Oliveira PR, Bernardi LS.

J Sep Sci · validation study; journal article · DOI 10.1002/jssc.201100258

Bibliografisk träff 2011-01-01

Lumiracoxib for acute postoperative dental pain: a systematic review of randomized clinical trials.

Silva RC, Riera R, Saconato H.

Sao Paulo Med J · meta-analysis; systematic review; review-article; journal article · DOI 10.1590/s1516-31802011000500009

Bibliografisk träff 2009-09-15

Liquid chromatographic determination of lumiracoxib in pharmaceutical formulations.

Oliveira PR, Bernardi LS, Mendes C, Sangoi MS, Silva MA.

J Pharm Biomed Anal · comparative study; journal article · DOI 10.1016/j.jpba.2009.09.008

Bibliografisk träff 2007-03-01

Lumiracoxib.

Buvanendran A, Barkin R.

Drugs Today (Barc) · review; journal article · DOI 10.1358/dot.2007.43.3.1062673

Bibliografisk träff 2004-06-01

Lumiracoxib (Prexige): a new selective COX-2 inhibitor.

Mysler E.

Int J Clin Pract · review; journal article · DOI 10.1111/j.1368-5031.2004.00199.x

Bibliografisk träff 2004-01-01

Clinical pharmacology of novel selective COX-2 inhibitors.

Tacconelli S, Capone ML, Patrignani P.

Curr Pharm Des · research support, non-u.s. gov't; review; journal article · DOI 10.2174/1381612043453108

Bibliografisk träff 2004-01-01

Lumiracoxib.

Lyseng-Williamson KA, Curran MP.

Drugs · comparative study; clinical trial; multicenter study; randomized controlled trial; journal article · DOI 10.2165/00003495-200464190-00008